Critical Illness Polyneuropathy and Myopathy

  • Galen V. Henderson


Critical illness polyneuropathy (CIP) and myopathy (CIM) are neuromuscular disorders that have been documented in critically ill patients admitted into intensive care units and are usually noted because of their failure to wean from mechanical ventilation. As a result of the diseases, there are increases in hospitalization length of stay, morbidity, and costs.


Severe Sepsis Status Epilepticus Systemic Inflammatory Response Syndrome Intensive Care Unit Patient Nerve Conduction Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bolton CF. Critical illness polyneuropathy and myopathy. Crit Care Med. 2001;29(12):2388–2390.PubMedCrossRefGoogle Scholar
  2. 2.
    de Letter MA, Schmitz PI, Visser LH, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med. 2001;29(12):2281–2286.PubMedCrossRefGoogle Scholar
  3. 3.
    Latronico N. Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both. Intensive Care Med. 2003;29(9):1411–1413.PubMedCrossRefGoogle Scholar
  4. 4.
    De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859–2867.PubMedCrossRefGoogle Scholar
  5. 5.
    Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol. 2005;252(3):343–351.PubMedCrossRefGoogle Scholar
  6. 6.
    Zochodne DW, Bolton CF, Wells GA. Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain. 1987;110(4):819–841.PubMedCrossRefGoogle Scholar
  7. 7.
    Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med. 1996;24(8):1408–1416.PubMedCrossRefGoogle Scholar
  8. 8.
    Hirano M, Ott BR, Raps EC, et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology. 1992;42(11):2082–2087.PubMedCrossRefGoogle Scholar
  9. 9.
    Rich MM, Raps EC, Bird SJ. Distinction between acute myopathy syndrome and critical illness polyneuropathy. Mayo Clin Proc. 1995;70(2):198–200.PubMedCrossRefGoogle Scholar
  10. 10.
    Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology. 1996;46(3):731–736.PubMedCrossRefGoogle Scholar
  11. 11.
    Rossignol B, Gueret G, Pennec JP, et al. Effects of chronic sepsis on the voltage-gated sodium channel in isolated rat muscle fibers. Crit Care Med. 2007;35(2):351–357.PubMedCrossRefGoogle Scholar
  12. 12.
    Young GB. Intensive care unit/critical illness myopathy: toward a unifying hypothesis. Crit Care Med. 2007;35(2):628–629.PubMedGoogle Scholar
  13. 13.
    Sandrock AW, Cros DP, Louis DN. Case 11-1997 – A 51-year-old man with chronic obstructive pulmonary disease and generalized muscle weakness. N Engl J Med. 1997;336(15):1079.CrossRefGoogle Scholar
  14. 14.
    Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology. 2006;67(8):1421–1425.PubMedCrossRefGoogle Scholar
  15. 15.
    Latronico N, Bertolini G, Guarneri B, et al. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care. 2007;11(1):R11.PubMedCrossRefGoogle Scholar
  16. 16.
    Schweickert WD, Hall J. ICU acquired weakness. Chest. 2007;131:1541–1549.PubMedCrossRefGoogle Scholar
  17. 17.
    van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically Ill patients. N Engl J Med. 2001;345(19):1359–1367.PubMedCrossRefGoogle Scholar
  18. 18.
    Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64(8):1348–1353.PubMedCrossRefGoogle Scholar
  19. 19.
    Visser LH. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol. 2006;13:1203–1212.PubMedCrossRefGoogle Scholar
  20. 20.
    Fletcher SN, Kennedy DD, Ghosh IR, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31:1012–1016.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Galen V. Henderson
    • 1
  1. 1.Department of Neurology, Harvard Medical SchoolBrigham and Womens HospitalBostonUSA

Personalised recommendations